Pritchard John N
Respironics Respiratory Drug Delivery (UK) Ltd, a business of Philips Electronics UK Limited, Chichester, West Sussex, UK.
Ther Deliv. 2017 Jun;8(6):391-399. doi: 10.4155/tde-2017-0015. Epub 2017 May 4.
In the later half of the 20th century, nebulized therapy was in decline, but in the 21st century the prospects for the expanded use of nebulized therapy within respiratory medicine look bright. The advent of mesh nebulizers, which combine the universal applicability of the nebulizer in the treatment of all respiratory patients with the convenience of portable inhaler use, is ideally timed to capitalize on the forecast of increased numbers of patients who will require nebulized therapy in the future. This special report will highlight some of the opportunities that the development of mesh nebulizers presents in the field of respiratory medicine.
在20世纪后半叶，雾化治疗呈下降趋势，但在21世纪，雾化治疗在呼吸医学领域扩大应用的前景一片光明。网状雾化器的出现，它将雾化器在治疗所有呼吸疾病患者方面的广泛适用性与便携式吸入器使用的便利性相结合，恰逢其时，正好可以利用未来需要雾化治疗的患者数量增加这一预测。本专题报告将重点介绍网状雾化器的发展在呼吸医学领域带来的一些机遇。
